Covid Drug Tested at UVA Gets Approval

Covid-19 Photo credit Getty Images

Charlottesville, Va. ( - A Covid-19 drug tested at UVA Health has now become the second drug fully approved by the FDA to hospitalized Covid-19 patients. Baricitinib was tested at UVA in 2020 and 2021.

The drug is meant for the most severe and hospitalized Covid-19 patients. It works by targeting inflammation. The patients most likely to receive it include those needing additional oxygen, or are on ventilators.

Approximately 40 patients at UVA Health helped with the testing.

Live On-Air
Ask Your Smart Speaker to Play News Radio W R V A
Newsradio 1140 WRVA
Listen Now
Now Playing
Now Playing